...
首页> 外文期刊>Antimicrobial agents and chemotherapy. >Use of the NP-40 detergent-mediated assay in discovery of inhibitors of beta-hematin crystallization.
【24h】

Use of the NP-40 detergent-mediated assay in discovery of inhibitors of beta-hematin crystallization.

机译:NP-40去污剂介导的测定在发现β-血红素结晶抑制剂中的应用。

获取原文
获取原文并翻译 | 示例
           

摘要

The protozoan parasite responsible for malaria affects over 500 million people each year. Current antimalarials have experienced decreased efficacy due to the development of drug-resistant strains of Plasmodium spp., resulting in a critical need for the discovery of new antimalarials. Hemozoin, a crystalline by-product of heme detoxification that is necessary for parasite survival, serves as an important drug target. The quinoline antimalarials, including amodiaquine and chloroquine, act by inhibiting the formation of hemozoin. The formation of this crystal does not occur spontaneously, and recent evidence suggests crystallization occurs in the presence of neutral lipid particles located in the acidic digestive vacuole of the parasite. To mimic these conditions, the lipophilic detergent NP-40 has previously been shown to successfully mediate the formation of beta-hematin, synthetic hemozoin. Here, an NP-40 detergent-based assay was successfully adapted for use as a high-throughput screen to identify inhibitors of beta-hematin formation. The resulting assay exhibited a favorable Z' of 0.82 and maximal drift of less than 4%. The assay was used in a pilot screen of 38,400 diverse compounds at a screening concentration of 19.3 muM, resulting in the identification of 161 previously unreported beta-hematin inhibitors. Of these, 48 also exhibited >/= 90% inhibition of parasitemia in a Plasmodium falciparum whole-cell assay at a screening concentration of 23 muM. Eight of these compounds were identified to have nanomolar 50% inhibitory concentration values near that of chloroquine in this assay.
机译:负责疟疾的原生动物寄生虫每年影响5亿多人。由于抗疟原虫属(Plasmodium spp。)的耐药菌株的发展,目前的抗疟药的功效下降,导致对发现新抗疟药的迫切需求。血红素是血红素解毒的结晶副产物,是寄生虫生存所必需的,它是重要的药物靶标。喹啉类抗疟药,包括阿莫地喹和氯喹,通过抑制血红蛋白的形成而起作用。该晶体的形成不是自发发生的,最近的证据表明,结晶是在寄生虫的酸性消化液中存在中性脂质颗粒的情况下发生的。为了模拟这些条件,亲脂性清洁剂NP-40先前已成功地介导了β-血红素(合成血红蛋白)的形成。在这里,基于NP-40去污剂的测定法成功地用作了高通量筛选,以鉴定β-血红素形成的抑制剂。所得测定显示出有利的Z'为0.82,最大漂移小于4%。该测定法以19.3μM的筛选浓度用于38,400种不同化合物的初步筛选,从而鉴定了161种以前未报道的β-血红素抑制剂。其中,在恶性疟原虫全细胞试验中,在48μM的筛选浓度下,有48种还表现出对寄生虫病的抑制,其抑制率达90%以上。在该测定中,鉴定出这些化合物中的八种具有接近氯喹的纳摩尔浓度的50%抑制浓度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号